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MmfL catalyses formation of a phosphorylated
butenolide intermediate in methylenomycin furan
biosynthesis†
Shanshan Zhou, a Nicolas R. Malet,a Lijiang Song, a Christophe Corre abc and
Gregory L. Challis *acd
Using a combination of a synthetic substrate analogue and product
standard, MmfL, a homologue of the c-butyrolactone biosynthetic
enzyme AfsA, was shown to catalyse the condensation of dihydroxy-
acetone phosphate with a b-ketoacyl thioester to form a phosphorylated
butenolide intermediate in the biosynthesis of the methylenomycin
furans, which induce methlenomycin antibiotic production in Strepto-
myces coelicolor A3(2). AfsA homologues are also involved in the
biosynthesis of 2-akyl-4-hydroxy-3-methyl butenolide inducers of anti-
biotic production in other Streptomyces species, indicating that diverse
signalling molecules are assembled from analogous phosphorylated
butenolide intermediates.
Bacterial specialized metabolites are one of the largest reser-
voirs of bioactive natural products, including antimicrobials,
antitumor agents, immunosuppressants, anthelmintics and
insecticides, herbicides and antifungal agents.1 The biosynth-
esis of bacterial specialized metabolites is often regulated by
signalling molecules known as autoregulators, autoinducers or
hormones.2,3 These diffusible small molecules induce specia-
lized metabolite production, and in some cases morphogen-
esis, by binding to specific transcriptional regulators.
Actinobacteria are prolific producers of specialized metabolites
that employ various signalling molecules to control their biosynth-
esis, including g-butyrolactones (GBLs), 2-alkyl-4-hydroxy-
methylfuran-3-carboxylic acids (AHFCAs),3,4 2-alkyl-4-hydroxy-3-
methylbutenolides (AHMBs) and avenolide (Fig. 1a–d).5–7 GBLs
have been identified in a range of Streptomyces species, such as
virginiae butanolides (VBs) A–E from Streptomyces virginiae, IM-2
from Streptomyces lavendulae FRI-5, SCBs 1–8 from Streptomyces
coelicolor A3(2) and A-factor from Streptomyces griseus (Fig. 1a and
e).8–13 These molecules all have similar structures, differing only in
the oxidation state, hydroxyl group configuration, position of
methyl branches and length of the alkyl chain.
A-factor, the first GBL to be discovered, induces production of
the antibiotic streptomycin and the yellow pigment grixazone in
S. griseus, in addition to morphological differentiation.13,14 AfsA
has been identified as key enzyme in A-factor biosynthesis that is
proposed to condense an acyl carrier protein (ACP)-bound b-keto
thioester intermediate in fatty acid biosynthesis with a 3-carbon
glycolytic intermediate. It has been reported to catalyse the
condensation of the N-acetylcysteamine (NAC) thioester of
8-methyl-3-oxononanoate with dihydroxyacetone phosphate
(DHAP) resulting in the formation of a phosphorylated buteno-
lide (Fig. 1e).15 Reduction of this butenolide to the corres-
ponding butanolide by BprA, followed by dephosphorylation
yields A-factor.
AfsA homologues have been reported to be involved in the
biosynthesis of other GBLs. For example, ScbA participates in
the assembly of SCBs in S. coelicolor and has been proposed to
consist of two divergent domains with similarity to the fatty
acid dehydratases FabA and FabZ.16,17 Interestingly, they are
also involved in the biosynthesis of other classes of Actinobac-
terial signalling molecules, such as AHFCAs and AHMBs. Thus,
MmfL and SabA participate in the assembly of methylenomycin
furans (MMFs) 1–5 and SABs 1–3, AHFCAs and AHMBs that
induce the production of methylenomycin and nikkomycin
antibiotics in S. coelicolor and Streptomyces ansochromogenes,
respectively (Fig. 1b and c and Fig. S1, ESI†).4,7 We hypothesize
that these enzymes catalyse analogous reactions to that
catalysed by AfsA and that GBLs, AHFCAs and AHMBs are all
assembled via intermediates with a common phosphorylated
butenolide core structure (Fig. 1f). Incorporation experiments
with stereospecifically 13C-labelled glycerols,18 which show that
the hydroxymethyl group of the MMFs derives from the
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corresponding functional group in DHAP, support this propo-
sal (Fig. 1f). However, there is currently no direct evidence for
the role played by MmfL in MMF biosynthesis. Here, we report
enzymatic characterization of purified recombinant MmfL
using a chemically synthesized substrate analogue and stan-
dard of the dephosphorylated product. These experiments
establish that MMF biosynthesis proceeds via a phosphorylated
butenolide intermediate, which undergoes dephosphorylation
and rearrangement to form the AHFCA skeleton.
We overproduced MmfL in E. coli as a soluble N-terminal
His6 fusion protein, enabling purification to homogeneity
using nickel affinity chromatography (Fig. S2a, ESI†). ESI-Q-
TOF-MS confirmed the identity of the purified protein (Fig. S2b,
ESI†). The substrate scope of MmfL appears to be comparatively
broad, as MMFs with various alkyl chains have been isolated
from S. coelicolor.4 We synthesised the NAC thioester of
3-ketooctanoate 1 (ESI†),19 which mimics the presumed
b-ketoacyl-ACP precursor of MMF5, and used this to investigate
the enzymatic activity of MmfL (Fig. 2a). His6-MmfL (15 mM),
was incubated with 1 (400 mM) and DHAP (400 mM) at 25 1C for
90 min and the mixture was treated with shrimp alkaline
phosphatase (SAP) to dephosphorylate the anticipated product
of the reaction, phosphorylated butenolide 2. A similar strategy
was used to overcome problems with detection of the
phosphorylated butenolide product in LC-MS analyses of
AfsA-catalysed reactions.15 A species with m/z = 235.0936,
Fig. 1 Structures of Streptomyces signalling molecules and proposed pathways for their biosynthesis. (a) GBLs, (b) AHFCAs, (c) AHMBs, (d) avenolide. (e) AfsA
catalyses the condensation of DHAP with a b-ketothioester in A-factor biosynthesis. (f) Proposed pathways for the biosynthesis of GBLs, AHMBs and AHFCAs,
involving intermediates with a common phosphorylated butenolide core structure (boxed). BprA catalyses reduction of the phosphorylated butenolide
intermediate in A-factor biosynthesis to the corresponding butanolide. ScbB is a BprA orthologue that is proposed to catalyse an analogous reaction in SCB
biosynthesis. Additional reductases convert the keto group to differently configured hydroxyl groups in the biosynthesis of VBs and SCBs/IM-2. Black dots
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corresponding to [M + Na]+ for butenolide 3 (calculated m/z for
C11H1604Na
+: 235.0941) was readily detected in UHPLC-ESI-Q-
TOF-MS analyses of the phosphatase-treated reaction mixture
(Fig. 2b). This species was absent from control reactions in
which either DHAP or 1 was omitted, or heat-denatured
MmfL was employed, confirming that it results from the
MmfL-catalysed condensation of 1 with DHAP.
Butenolides such as 3 are reported in the literature to be
unstable20 and this proved to be the case for the product of the
MmfL-catalysed reaction, which decomposed during attempts
to purify it using preparative HPLC. Thus, we synthesised an
authentic standard of 3 to compare with the dephosphorylated
product of the enzymatic reaction. Using methodology reported
by Sello and co-workers, we prepared the tert-butyldimethylsilyl
(TBDMS)-protected derivative 4 of butenolide 3 (Fig. 3a).21 The
structure of 4, which was also found to be somewhat unstable
and degraded during prolonged storage at 20 1C, was
confirmed using HRMS in combination with 1H and 13C NMR
spectroscopy (ESI†). Removal of the TBDMS group from 4 under
mild conditions (HF–pyridine complex, THF, 0 1C for 40 min),
followed by immediate UHPLC-ESI-Q-TOF-MS analysis con-
firmed that it has the same retention time as the dephosphory-
lated product of the MmfL-catalysed reaction (Fig. 3b).
Moreover, identical fragmentation patterns were observed in
MS/MS analyses of the [M + H]+ ions corresponding to the
products of the two reactions (Fig. 3c). We thus conclude that
the product of the MmfL-catalysed condensation of 1 with
DHAP is phosphorylated butenolide 2 (Fig. 2).
In addition to MmfL, two other enzymes, MmfP and MmfH,
are known to be required for MMF biosynthesis in S. coelicolor
(Fig. S1a, ESI†).22 MmfP is a putative phosphatase that likely
catalyses dephosphorylation of the phosphorylated butenolide
intermediates formed by MmfL to form the corresponding
2-acyl-3-hydroxymethylbutenolides (Fig. 1). This suggests that
MmfH, which exhibits sequence similarity to Flavin-dependent
oxidoreductases, catalyses conversion of the 2-acyl-3-hydro-
xymethylbutenolides formed by MmfP to the MMFs (Fig. 1).
While further experiments are required to substantiate this
hypothesis, a plausible mechanism for this transformation
involves hydroxylation of C-4 in the butenolide intermediates
by Flavin-hydroperoxide, generated by the reaction of
Fig. 2 (a) MmfL-catalysed condensation of DHAP with 1. Products were
dephosphorylated by treating with shrimp alkaline phosphatase (SAP) prior
to analysis. (b) Extracted ion chromatograms (EICs) for m/z = 235.0941,
corresponding to [M + Na]+ for 3, from UHPLC-ESI-Q-TOF-MS analyses of
the MmfL-catalysed reaction (top trace) and control reactions containing
heat-denatured MmfL (second from top), lacking DHAP (second from
bottom) and lacking 1 (bottom).
Fig. 3 (a) Synthesis of TBDMS-protected butenolide 4. (b) EICs for
m/z = 235.0941, corresponding to [M + Na]+ for 3, from UHPLC-ESI-Q-
TOF-MS analyses of the dephosphorylated product of the MmfL-catalysed
reaction (top), the deprotection of 4 (middle), and a mixture of the
products of these two reactions (bottom). (c) MS/MS spectra of the
m/z = 213 ion, corresponding to [M + H]+ for 3, observed for the products
resulting from the deprotection of 4 (top) and the SAP-treated




































































































14446 | Chem. Commun., 2020, 56, 14443--14446 This journal is©The Royal Society of Chemistry 2020
MmfH-bound FADH2 with molecular oxygen (Fig. 4). The
resulting 2-acyl-3-hydroxymethyl-4-hydroxybutenolides would
be expected to undergo facile ring opening, enabling furan
formation via a cyclisation–dehydration–tautomerisation
cascade (Fig. 4). This yields the corresponding 2-alkyl-4-formyl-
furan-3-carboxylic acids, which upon reduction of the formyl
group (possibly by MmfH-bound FADH2) would afford the MMFs
(Fig. 4). Consistent with this mechanism, 18O is incorporated
specifically into the hydroxymethyl group of MMF1 when
S. coeliclor is grown under an 18O2 atmosphere (Fig. 4 and
Fig. S12 and S13, ESI†).
Very recently, we and others have reported the discovery of
gladiostatin (also called gladiofungin A) as the product of a
cryptic trans-AT polyketide synthase (PKS) in Burkholderia
gladioli.23,24 This unique member of the glutarimide family of
antibiotics contains a 2-acyl-4-hydroxy-3-methylbutenolide that
is closely related to the butenolide core of the AHMB signalling
molecules. We showed that an AfsA-like domain appended to
the C-terminus of the PKS releases the fully assembled chain by
condensing it with DHAP, resulting in the same type of
phosphorylated butenolide intermediate as that produced by
AfsA and MmfL in A-factor and MMF biosynthesis. Accordingly,
we have proposed ‘‘phosphorylated butenolide synthase’’ as a
collective name for this enzyme family.23 It seems likely that the
biosynthesis of AHMB signalling molecules such as the SRBs
and the SABs, which also involves AfsA homologues, proceeds
via analogous phosphorylated butenolide intermediates to
those involved in the biosynthesis of GBLs and AHFCAs
(Fig. 1f). Together these findings illuminate a fascinating
example of how Nature is able to evolve pathways for the
assembly of diverse molecular architectures from a common
type of biosynthetic intermediate.
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Fig. 4 Proposed mechanism for MmfH-catalysed conversion of 2-acyl-
3-hydroxymethylbutenolides generated by MmfP to the MMFs. The
O atom labelled in the MMFs when S. coelicolor is grown under an
18O2 atmosphere is highlighted in blue.
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